Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Walter Ling, M.D.
Los Angeles Treatment Research Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Betty Ford Center
Rancho Mirage, California, United States
- the Center for Drug-Free Living
Orlando, Florida, United States
- Operation Par, Inc.
Pinellas Park, Florida, United States
- Self Help Addiction Rehabilitation (shar), Inc.
Detroit, Michigan, United States
- Phoenix House
New York, New York, United States
- Maryhaven, Inc.
Columbus, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2001
- Primary completion
- 31 Aug 2002
- Completion
- 31 Aug 2002
- Last update posted
- 12 Jan 2017
- Registered enrollment
- 163
- Registry id
- NCT00032955
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.